Ariane de Jesus Sousa Batista

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Tecnologia

Unidade:

Coordenação dos Programas de Pós-Graduação de Engenharia

Departamento:

Programa de Engenharia Química/COPPE

ORCID:

https://orcid.org/0000-0002-1642-6669


Formação:
  • Laboratório de Imunofarmacologia - IBCCF/UFRJ

    | Pós-Doutorado | 2017 - 2018
  • Laboratório de Imunofarmacologia - IBCCF/UFRJ

    | Pós-Doutorado | 2016 - 2017
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Doutorado | 2013 - 2016
  • Universidade Federal do Rio de Janeiro

    Farmácia Bioquímica - opção análises clínicas | Especialização | 2011 - 2013
  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Biofísica) | Mestrado | 2011 - 2013
  • Escola Nacional de Saúde Pública

    Curso de Especialização em Vigilância Sanitária | Especialização | 2010 - 2011
  • Universidade Federal do Rio de Janeiro

    Habilitação Farmacêutico Industrial | Especialização | 2009 - 2012
  • Universidade Federal do Rio de Janeiro

    Farmácia - Habilitação Farmacêutico Industrial | Graduação | 2005 - 2009
  • Escola Técnica Federal de Química do Rio de Janeiro

    Técnico em Biotecnologia | Ensino Profissional de nível técnico | 2001 - 2005
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(100.00% artigos com DOI)

Titulo DOI Ano
In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis 10.3390/pharmaceutics15010051 2023
Polymeric nanoparticles as therapeutic agents against coronavirus disease 10.1007/s11051-022-05396-5 2022
Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe 10.1016/j.biopha.2022.112784 2022
Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles 10.1017/s0031182020000712 2020
Effects of Different Stabilizers on Miniemulsion Methyl Methacrylate Polymerizations 10.1002/masy.202000143 2020
Leishmanicidal therapy targeted to parasite proteases 10.1016/j.lfs.2019.01.015 2019
Ultraspecific live imaging of the dynamics of zebrafish neutrophil granules by a histopermeable fluorogenic benzochalcone probe 10.1039/c8sc05593a 2019
Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-Loaded microparticles 10.1016/j.ijpddr.2019.06.001 2019
Encapsulation in lipid-core nanocapsules improves topical treatment with the potent antileishmanial compound CH8 10.1016/j.nano.2019.102121 2019
Broad spectrum and safety of oral treatment with a promising nitrosylated chalcone in murine leishmaniasis 10.1128/aac.00792-18 2018
Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis 10.1080/03639045.2018.1461903 2018
Mesoporous silica as multiple nanoparticles systems for inflammation imaging as nano-radiopharmaceuticals 10.1016/j.micromeso.2016.10.041 2017
Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis 10.1097/mjt.0000000000000539 2017
Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis 10.1017/S003118201700097X 2017
New Chalcone Compound as a Promising Antileishmanial Drug for an Old Neglected Disease: Biological Evaluation using Radiolabeled Biodistribution 10.1016/j.jgar.2017.11.012 2017
Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis 10.1128/AAC.01822-17 2017
Nanoradiopharmaceuticals for Nanomedicine: Building the Future 10.2174/1877912305666150101235646 2015
Os desafios da nanotecnologia para a vigilância sanitária de medicamentos 10.1590/1413-81232014197.02462013 2014
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
Novel Single-Dose Intralesional Treatment Of Cutaneous Leishmaniasis With Amphotericin B: Ampho-Depot® 2022
Nanocrystallization of NAT22 chalcone for oral treatment of cutaneous leishmaniasis 2022
Development of microparticulated implants by spray drying for sustained release of antileishmanial drugs 2022
Device To Synthesize Amphotericin B-Loaded Polymeric Nanoparticles For Cutaneous Leishmaniasis Treatment 2022
Technological development of a new vaccine candidate against canine visceral leishmaniasis caused by Leishmania infantum. 2022
Chalcone nanocrystals for oral treatment of cutaneous leishmaniasis. 2022
Ampho-Depot®: Single-Dose Intralesional Formulation With Amphotericin B For The Treatment Of Cutaneous Leishmaniasis. 2022
Sterilization Of Plga-Amphotericin B Microparticles By Gamma Irradiation 2022
Nanotoxicology: Scopus and Pubmed Data Mining and Bibliographic Map Comparative Analysis Using VOSviewer Software. 2022
Publicações:
Minha Rede: